252
Participants
Start Date
October 31, 2011
Primary Completion Date
January 31, 2012
Study Completion Date
January 31, 2012
MenACWY-CRM
Novartis meningococcal ACWY conjugate vaccine will be administered intramuscularly (IM) on day 1.
Combined inactivated hepatitis A & recombinant hepatitis B
Combined inactivated hepatitis A and recombinant hepatitis B vaccine will be administered by IM on days 1, 8 \& 29 for subjects unprimed with hepatitis A and B; and a single booster injection on day 1 for primed subjects.
Recombinant hepatitis B vaccine
Recombinant hepatitis B vaccine will be administered intramuscularly on days 8 and 29
Inactivated hepatitis A vaccine
Inactivated hepatitis A will be administered intramuscularly on days 8 and 29.
03, Novartis Investigational Site, Berlin
04, Novartis Investigational Site, Rostock
02, Novartis Investigational Site, Hamburg
01, Novartis Investigational Site, München
Lead Sponsor
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Novartis Vaccines
INDUSTRY